Literature DB >> 29118174

FDA-CDC Antimicrobial Resistance Isolate Bank: a Publicly Available Resource To Support Research, Development, and Regulatory Requirements.

Joseph D Lutgring1,2, María-José Machado3, Faiza H Benahmed4, Patricia Conville4, Ribhi M Shawar4, Jean Patel3, Allison C Brown3.   

Abstract

The FDA-CDC Antimicrobial Resistance Isolate Bank was created in July 2015 as a publicly available resource to combat antimicrobial resistance. It is a curated repository of bacterial isolates with an assortment of clinically important resistance mechanisms that have been phenotypically and genotypically characterized. In the first 2 years of operation, the bank offered 14 panels comprising 496 unique isolates and had filled 486 orders from 394 institutions throughout the United States. New panels are being added.
Copyright © 2018 American Society for Microbiology.

Keywords:  AR Bank; AR Isolate Bank; antibiotic resistance; antimicrobial resistance

Mesh：

Substances：

Year:  2018        PMID： 29118174      PMCID： PMC5786719          DOI： 10.1128/JCM.01415-17

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  5 in total

Review 1.  Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America.

Authors:  Helen W Boucher; George H Talbot; John S Bradley; John E Edwards; David Gilbert; Louis B Rice; Michael Scheld; Brad Spellberg; John Bartlett
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

Review 2.  The emergent needs for basic research, education, and surveillance of antimicrobial resistance. Problems facing the report from the American Society for Microbiology Task Force on Antibiotic Resistance.

Authors:  R N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  1996-08       Impact factor: 2.803

3.  Antibiotic misuse: a global crisis.

Authors:  Michael Bell
Journal:  JAMA Intern Med       Date:  2014-12       Impact factor: 21.873

4.  The United Nations and the Urgent Need for Coordinated Global Action in the Fight Against Antimicrobial Resistance.

Authors:  Helen W Boucher; Johan S Bakken; Barbara E Murray
Journal:  Ann Intern Med       Date:  2016-09-20       Impact factor: 25.391

5.  Kraken: ultrafast metagenomic sequence classification using exact alignments.

Authors:  Derrick E Wood; Steven L Salzberg
Journal:  Genome Biol       Date:  2014-03-03       Impact factor: 13.583
  5 in total
  20 in total

1.  A Diverse Panel of Clinical Acinetobacter baumannii for Research and Development.

Authors:  Madeline R Galac; Erik Snesrud; Francois Lebreton; Jason Stam; Michael Julius; Ana C Ong; Rosslyn Maybank; Anthony R Jones; Yoon I Kwak; Kate Hinkle; Paige E Waterman; Emil P Lesho; Jason W Bennett; Patrick Mc Gann
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

2.  Performance of ceftazidime/avibactam susceptibility testing methods against clinically relevant Gram-negative organisms.

Authors:  E Wenzler; M Lee; T J Wu; K A Meyer; R K Shields; M H Nguyen; C J Clancy; R M Humphries; A T Harrington
Journal:  J Antimicrob Chemother       Date:  2019-03-01       Impact factor: 5.790

3.  Evaluation of the MicroScan Colistin Well and Gradient Diffusion Strips for Colistin Susceptibility Testing in Enterobacteriaceae.

Authors:  Joseph D Lutgring; Anny Kim; Davina Campbell; Maria Karlsson; Allison C Brown; Eileen M Burd
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

4.  Insights into the Unique Nature of the East Asian Clade of the Emerging Pathogenic Yeast Candida auris.

Authors:  Rory M Welsh; D Joseph Sexton; Kaitlin Forsberg; Snigdha Vallabhaneni; Anastasia Litvintseva
Journal:  J Clin Microbiol       Date:  2019-03-28       Impact factor: 5.948

Review 5.  Expanding U.S. Laboratory Capacity for Neisseria gonorrhoeae Antimicrobial Susceptibility Testing and Whole-Genome Sequencing through the CDC's Antibiotic Resistance Laboratory Network.

Authors:  Ellen N Kersh; Cau D Pham; John R Papp; Robert Myers; Richard Steece; Grace Kubin; Romesh Gautom; Evelyn E Nash; Samera Sharpe; Kim M Gernert; Matthew Schmerer; Brian H Raphael; Tara Henning; Anne M Gaynor; Olusegun Soge; Karen Schlanger; Robert D Kirkcaldy; Sancta B St Cyr; Elizabeth A Torrone; Kyle Bernstein; Hillard Weinstock
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

6.  Locus CauMT1 Provides a Higher-Resolution Alternative to Ribosomal Gene Sequencing for Initial Candida auris Genotyping.

Authors:  Santosh Katiyar; Tom Edlind
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

7.  A naturally inspired antibiotic to target multidrug-resistant pathogens.

Authors:  Zongqiang Wang; Bimal Koirala; Yozen Hernandez; Matthew Zimmerman; Steven Park; David S Perlin; Sean F Brady
Journal:  Nature       Date:  2022-01-05       Impact factor: 49.962

8.  Bringing Antimicrobial Susceptibility Testing for New Drugs into the Clinical Laboratory: Removing Obstacles in Our Fight against Multidrug-Resistant Pathogens.

Authors:  James E Kirby; Thea Brennan-Krohn; Kenneth P Smith
Journal:  J Clin Microbiol       Date:  2019-11-22       Impact factor: 5.948

9.  Potentiated antimicrobial blue light killing of methicillin resistant Staphylococcus aureus by pyocyanin.

Authors:  Leon G Leanse; Xiaojing Zeng; Tianhong Dai
Journal:  J Photochem Photobiol B       Date:  2021-01-21       Impact factor: 6.252

10.  Untargeted Metabolomics Reveals Species-Specific Metabolite Production and Shared Nutrient Consumption by Pseudomonas aeruginosa and Staphylococcus aureus.

Authors:  Laura J Dunphy; Kassandra L Grimes; Nishikant Wase; Glynis L Kolling; Jason A Papin
Journal:  mSystems       Date:  2021-06-22       Impact factor: 6.496
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.